This instrumental variables analysis estimates that Medicare would realize $362 million in annual savings if all patients with newly diagnosed low back pain were managed conservatively.
Osteoporosis treatment for high-risk women is cost-effective, with bisphosphonates providing the most benefit at the lowest cost.
No One Left Behind, a program to provide financial assistance and access to cancer care at Carolina Blood and Cancer Care Associates in South Carolina, will be discussed during a session of the Community Oncology Alliance 2022 Community Oncology Conference.
No corporate weight control program has ever reported savings or even sustained weight loss using valid metrics across a sizable population for 2 years or more, accounting for dropouts and nonparticipants. Further, these programs can harm morale and even the health of the employees themselves.
Geisinger’s Ask-a-Doc program, which enables direct asynchronous communication between primary and specialty care, was associated with lower healthcare utilization and cost, implying more efficient care.
Despite universal access to HER2 testing in Ontario, variability in reporting by region and disease severity presents challenges for program evaluation and quality improvement initiatives.
Commercial health plans promote the use of health IT to support behavioral health care access and delivery.
This article presents a synthesis of opioid use disorder guidelines and a framework to link them to claims data and recognize higher-quality practice, monitor outcomes, and individualize intervention.
We examined the impact of electronic reminders followed by performance reports and financial incentives. Physicians responded more to reports and incentives than to reminders alone.
Pharmacy benefit designs that mandate mail pharmacy use interfere with prescription drug access, particularly for individuals without previous mail pharmacy experience.
Physician-specific, aggregate patient medication adherence data vary significantly and provide an expanded focus for interventions to improve patient adherence to treatment.
Patients with complex chronic disease can be grouped by varying propensity for health care continuity patterns, which could be harnessed to personalize health care utilization interventions.
We present an International Classification of Diseases, Tenth Revision (ICD-10) translation of the adapted Diabetes Complications Severity Index and show its performance in predicting hospitalizations, mortality, and healthcare-associated costs.
A growing body of evidence is demonstrating how the benefits of Connected Care, electronic communication between patient and caregiver, are improving healthcare access and quality and reducing costs for payers-without passing through Congress.
Nonwhite race, smoking, and increasing body mass index were associated with the lowest adherence trajectories for patients with heart failure, with adherence dropping off within the first year.
The mean 24-week cost per participant was $5416 for extended-release injectable naltrexone (57% detoxification, 37% medication, 6% provider/patient) and $4148 for buprenorphine-naloxone (64% detoxification, 12% medication, 24% provider/patient).